Empowering effective biomarker-driven precision oncology: A call to action-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Empowering effective biomarker-driven precision oncology: A call to action

Published:2024-09 Issue: Volume:209 Page:114225
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Lawler Mark,Keeling Peter,Kholmanskikh Olga,Minnaard Warnyta,Moehlig-Zuttermeister Heike,Normanno Nicola,Philip Reena,Popp Claudia,Salgado Roberto,Santiago-Walker Ademi E.,Trullas Ana,van Doorn-Khosrovani Sahar B. van Waalwijk,Vart Richard,Vermeulen Jessica,Vitaloni Marianna,Verweij Jaap

Publisher

Elsevier BV

Reference33 articles.

1. Cancer biomarkers in the era of precision oncology: addressing the needs of patients and health systems;Normanno;Semin Cancer Biol,2022

2. Personalized cancer medicine: are we there yet?;Lawler;Oncologist,2013

3. Trends in the approval of cancer therapies by the FDA in the twenty-first century;Scott;Nat Rev Drug Discov,2023

4. Cancer Research UK (2023a) Why is early cancer diagnosis important? Available at: https://www.cancerresearchuk.org/https://www.cancerresearchuk.org/about-cancer/spot-cancer-early/why-is-early-diagnosis-important.

5. ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group;Pascual;Ann Oncol,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP